Last reviewed · How we verify

EGb761 — Competitive Intelligence Brief

EGb761 (EGb761) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / Neuroprotective agent. Area: Neurology / Cognitive disorders.

phase 3 Herbal extract / Neuroprotective agent Neurology / Cognitive disorders Small molecule Live · refreshed every 30 min

Target snapshot

EGb761 (EGb761) — Ipsen. EGb761 is a standardized Ginkgo biloba extract that enhances cerebral blood flow and provides neuroprotection through antioxidant and anti-inflammatory mechanisms.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
EGb761 TARGET EGb761 Ipsen phase 3 Herbal extract / Neuroprotective agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / Neuroprotective agent class)

  1. Ipsen · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). EGb761 — Competitive Intelligence Brief. https://druglandscape.com/ci/egb761. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: